Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer

Anticancer Research

Volumn 29, Issue 1, 2009, Pages 271-273

  Hibi, Kenji ^a   Mizukami, Hiroki ^a   Shirahata, Atsushi ^a   Goto, Tetsuhiro ^a   Sakata, Makiko ^a   Saito, Mitsuo ^a   Ishibashi, Kazuyoshi ^a   Kigawa, Gaku ^a   Nemoto, Hiroshi ^a   Sanada, Yutaka ^a  

^a SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Colorectal cancer; Quantitative methylation specific PCR; UNC5C

Indexed keywords

NETRIN 1;

ADULT; AGED; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UNC5C GENE;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, CELL SURFACE; YOUNG ADULT;

EID: 61449126084     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, van Boom JH, van der Eb AJ and Vogelstein B: Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293-297, 1987.
2. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, Koyama K, Utsunomiya J, Baba S, Hedge P, Markham A, Krush AJ, Petersen G, Hamilton SR, Nilbert MC, Levy DB, Bryan TM, Preesinger AC, Smith KJ, Su LK, Kinzler KW and Vogelstein B: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669, 1991.
3. Baker SJ, Markowitz S, Fearon ER, Willson JK and Vogelstein B: Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915, 1990.
4. Hibi K, Nakamura H, Hirai A, Fujikake Y, Kasai Y, Akiyama S, Ito K and Takagi H: Loss of H19 imprinting in esophageal cancer. Cancer Res 56: 480-482, 1996.
5. Hibi K, Taguchi M, Nakamura H, Hirai A, Fujikake Y, Matsui T, Kasai Y, Akiyama S, Ito K and Takagi H: Alternative splicing of the FHIT gene in colorectal cancer. Jpn J Cancer Res 88: 385-388, 1997.
6. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM and Bos JL: Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525-532, 1988.
7. Ackerman SL, Kozak LP, Przyborski SA, Rund LA, Boyer BB and Knowles BB: The mouse rostral cerebellar malformation gene encodes an UNC-5-like protein. Nature 389: 838-842, 1997.
8. Hong K, Hinck L, Nishiyama M, Poo MM, Tessier-Lavigne M and Stein E: A ligand-gated association between cytoplasmic domains of UNC5 and DCC family receptors converts netrin-induced growth cone attraction to repulsion. Cell 97: 927-941, 1999.
9. Llambi F, Causeret F, Bloch-Gallego L and Mehlen P: Netrin-1 acts as a survival factor via its receptors UNC5H and DCC. EMBO J 20: 2715-2722, 2001.
10. Thiebault K, Mazelin L, Pays L, Llambi F, Joly MO, Scoazec JY, Saurin JC, Romeo G and Mehlen P: The netrin-1 receptors UNC5H are putative tumor suppressors cotrolling cell death commitment. Proc Natl Acad Sci USA 100: 4173-4178, 2003.
11. Bernet A, Mazelin L, Coissieux M-M, Gadot N, Ackerman SL, Scoazec J-Y and Mehlen P: Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterol 133: 1840-1848, 2007.
12. Shin SK, Nagasaka T, Jung BH, Matsubara N, Kim WH, Carethers JM, Boland CR and Goel A: Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer. Gastroenterol 133: 1849-1857, 2007.
13. Hibi K, Taguchi M, Nakayama H, Takase T, Kasai Y, Ito K, Akiyama S and Nakao A: Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 7: 3135-3138, 2001.
14. Greenlee RT, Murray T, Bolden S and Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 50: 7-33, 2000.
15. Hibi K, Nakayama H, Koike M, Kasai Y, Ito K, Akiyama S and Nakao A: Colorectal cancers with both p16 and p14 methylation show invasive characteristics. Jpn J Cancer Res 93: 883-887, 2002.
16. Hibi K, Nakayama H, Kodera Y, Ito K, Akiyama S and Nakao A: CDH13 promoter region is specifically methylated in poorly differentiated colorectal cancer. Br J Cancer 90: 1030-1033, 2004.
17. Hibi K and Nakao A: Highly-methylated colorectal cancers show poorly-differentiated phenotype. Anticancer Res 26: 4263-4266, 2006.